Active Ingredient History
Estradiol 3-sulfate or 17beta-estradiol 3-sulfate is a biologically inactive metabolite of estradiol, which can be converted by steryl sulfatase again to the parent estrogen. NCATS
Drug Pricing (per unit)
Note: This drug pricing data is preliminary, incomplete, and may contain errors.
Combination drugs
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Atrophic Vaginitis (approved 1974)
Osteoporosis, Postmenopausal (approved 1974)
Abortion, Spontaneous (Phase 4)
Adenomyosis (Phase 3)
Aging (Phase 4)
Aging, Premature (Phase 4)
Alzheimer Disease (Phase 2/Phase 3)
Amenorrhea (Phase 2)
Anemia (Phase 3)
Anorexia Nervosa (Phase 3)
Anovulation (Phase 4)
Arteriosclerosis (Phase 4)
Asthma (Phase 2)
Ataxia Telangiectasia (Phase 4)
Atherosclerosis (Phase 4)
Atrophic Vaginitis (Phase 4)
Atrophy (Phase 4)
Back Pain (Phase 2)
Body Weight Changes (Phase 4)
Bone Diseases, Metabolic (Phase 3)
BRCA1 Protein (Phase 2)
Breast Neoplasms (Phase 4)
Bulimia Nervosa (Phase 2)
Burns (Phase 3)
Cardiovascular Diseases (Phase 4)
Cerebral Arterial Diseases (Early Phase 1)
Cesarean Section (Phase 4)
Cicatrix (Phase 2)
Climacteric (Phase 4)
Cognition Disorders (Phase 4)
Contraception (Phase 4)
Contraception Behavior (Phase 4)
Contraceptive Agents (Phase 2)
Contraceptives, Oral (Phase 4)
Coronary Disease (Phase 3)
COVID-19 (Phase 2)
Cystic Fibrosis (Phase 4)
Cystitis, Interstitial (Phase 2)
Deficiency Diseases (Phase 2)
Dementia (Phase 1)
Depression (Phase 4)
Depression, Postpartum (Phase 4)
Depressive Disorder, Major (Phase 1/Phase 2)
Diabetes Mellitus, Type 1 (Phase 1)
Diabetes Mellitus, Type 2 (Phase 1)
Dry Eye Syndromes (Phase 2)
Dysbiosis (Phase 4)
Dysmenorrhea (Phase 4)
Dyspareunia (Phase 4)
Embryo Transfer (Phase 4)
Emotions (Phase 1)
Endometrial Hyperplasia (Phase 2)
Endometrial Neoplasms (Phase 4)
Endometriosis (Phase 3)
Endometrium (Phase 4)
Estradiol (Phase 2)
Estrogen Replacement Therapy (Phase 4)
Estrogens (Phase 4)
Exercise (Phase 3)
Fatigue Syndrome, Chronic (Phase 2)
Fear (Phase 1/Phase 2)
Feeding and Eating Disorders (Phase 2)
Fertilization in Vitro (Phase 4)
Fibromyalgia (Phase 2)
Gender Dysphoria (Phase 4)
General Surgery (Phase 4)
Genetic Diseases, Inborn (Phase 3)
Growth and Development (Phase 4)
Gynatresia (Phase 2)
Headache (Phase 3)
Healthy Volunteers (Phase 4)
Heart Diseases (Phase 4)
Hemostasis (Phase 1/Phase 2)
HIV (Phase 1)
HIV Infections (Phase 4)
Hormone Replacement Therapy (Phase 4)
Hormones (Phase 4)
Hot Flashes (Phase 4)
Hyperandrogenism (Phase 4)
Hypercalciuria (Phase 2)
Hypertension (Phase 4)
Hyperuricemia (Phase 4)
Hypogonadism ()
Infertility (Phase 4)
Infertility, Female (Phase 4)
Infertility, Male (Phase 4)
Insulin Resistance (Phase 4)
Intracranial Aneurysm (Phase 2)
Irritable Bowel Syndrome (Phase 2)
Labor, Obstetric (Phase 2/Phase 3)
Leiomyoma (Phase 3)
Libido (Phase 3)
Memory (Phase 1)
Memory Disorders (Phase 4)
Menopause (Phase 4)
Menorrhagia (Phase 4)
Menstruation Disturbances (Phase 4)
Mental Health (Phase 4)
Metabolism (Phase 1/Phase 2)
Metrorrhagia (Phase 3)
Migraine Disorders (Phase 4)
Multiple Sclerosis (Phase 3)
Mutation (Phase 2)
Myocardial Ischemia (Phase 3)
Neoplasms (Phase 2)
Non-alcoholic Fatty Liver Disease (Phase 3)
Obesity (Phase 3)
Orthostatic Intolerance (Phase 2)
Osteoporosis (Phase 4)
Ovarian Diseases (Phase 2)
Ovarian Hyperstimulation Syndrome (Phase 4)
Ovarian Reserve (Phase 4)
Ovulation (Phase 4)
Ovulation Inhibition (Phase 4)
Oxytocin (Phase 1)
Pain (Phase 3)
Pelvic Floor Disorders (Phase 4)
Pelvic Organ Prolapse (Phase 4)
Pelvic Pain (Phase 3)
Perimenopause (Phase 4)
Pharmacology, Clinical (Phase 1)
Polycystic Ovary Syndrome (Phase 4)
Postmenopause (Phase 4)
Pregnancy Complications (Phase 4)
Pregnancy, Unplanned (Phase 2)
Premenopause (Phase 4)
Primary Ovarian Insufficiency (Phase 4)
Progesterone (Phase 4)
Prostatic Neoplasms (Phase 3)
Prostheses and Implants (Phase 4)
Psoriasis (Phase 2)
Psychotic Disorders (Phase 3)
Pulmonary Disease, Chronic Obstructive (Phase 2)
Rhinitis, Allergic, Seasonal (Phase 2)
Schizophrenia (Phase 3)
Sexual Behavior (Phase 4)
Sexual Dysfunction, Physiological (Phase 3)
Signs and Symptoms (Phase 4)
Sleep Wake Disorders (Phase 4)
Sperm Injections, Intracytoplasmic (Phase 3)
Stress Disorders, Post-Traumatic (Phase 1)
Suicidal Ideation (Phase 4)
Temporomandibular Joint Disorders (Phase 2)
Tension-Type Headache (Phase 2)
Therapeutic Equivalency (Phase 1)
Therapeutics (Phase 2)
Thinness (Phase 4)
Thrombophilia (Phase 4)
Transgender Persons (Phase 1)
Transsexualism (Phase 4)
Turner Syndrome (Phase 4)
Urinary Tract Infections (Phase 4)
Urination Disorders (Phase 3)
Uterine Diseases (Phase 2)
Uterine Hemorrhage (Phase 4)
Vaginal Diseases (Phase 4)
Vaginitis (Phase 4)
Vaginosis, Bacterial (Phase 1)
Varicose Ulcer (Phase 3)
Vascular Diseases (Phase 2)
Vasodilation (Phase 4)
Vasomotor System (Phase 4)
Venous Thrombosis (Phase 4)
Ventricular Dysfunction, Left (Phase 4)
Vulvar Diseases (Phase 3)
Vulvodynia (Phase 2)
Women (Phase 2)
Wound Healing (Phase 2)
Wounds and Injuries (Phase 3)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue
